View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
April 5, 2011

New Test Could Identify Lung Cancer in Non-Smokers

Researchers at Celera Corporation have developed a biomarker-based serum test to identify lung cancer in people who have never smoked. To establish the biomarkers, researchers examined more than 600 samples of patients with non-small cell lung cancer. Once the biomarkers wer

By cms admin

Researchers at Celera Corporation have developed a biomarker-based serum test to identify lung cancer in people who have never smoked.

To establish the biomarkers, researchers examined more than 600 samples of patients with non-small cell lung cancer.

Once the biomarkers were determined, they conducted additional studies in 80 people who had never smoked, of whom 40 had various stages of cancer histological cell types and 40 were control subjects.

Researchers found that the serum test demonstrated strong performance, with sensitivity and specificity of 83%.

In addition, the test distinguished all stages of lung cancer and histological cell types.

Researchers are planning to conduct further studies to confirm the findings.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management